Results 51 to 60 of about 4,071 (233)

Off-Label Use of 0.19 mg Fluocinolone Acetonide Intravitreal Implant: A Systematic Review

Journal of Ophthalmology, 2021
Corticosteroids are used in a variety of ophthalmological diseases. One challenge faced by ophthalmologists is to deliver corticosteroids to the posterior segment of the eye with efficacy and safety.
Flávio Ribeiro, Manuel S. Falcão
doaj   +1 more source

Viral Retinitis following Intraocular or Periocular Corticosteroid Administration: A Case Series and Comprehensive Review of the Literature. [PDF]

, 2014
Purpose: To describe viral retinitis following intravitreal and periocular corticosteroid administration. Methods: Retrospective case series and comprehensive literature review. Results: We analyzed 5 unreported and 25 previously published cases of viral
Brown, D.M., Chan, C.C., Cunningham, E.T., Goldstein, D.A., Guex-Crosier, Y., Takakura, A., Tessler, H.H., Thorne, J.E., Wang, R.   +8 more
core   +1 more source

Anti‐CD20 therapy for multiple sclerosis‐associated uveitis: A case series

European Journal of Neurology, Volume 29, Issue 10, Page 3028-3038, October 2022., 2022
Approximately 1% of patients with multiple sclerosis (MS) have uveitis, but data on the effects of immunotherapies for MS on MS‐associated uveitis are scarce. In a retrospective study of 12 eyes of six patients with MS‐associated uveitis refractory to previous immunotherapies, we investigated the ophthalmological and neurological outcomes in patients ...
Frauke Stascheit, Anne Rübsam, Carolin Otto, Andreas Meisel, Klemens Ruprecht, Uwe Pleyer   +5 more
wiley   +1 more source

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T., Bonfiglio V., Fallico M., Fichera S., Longo A., Macchi I., Pizzo A., Rapisarda C., Reibaldi M., Russo A.   +9 more
core   +2 more sources

Medical therapies for melasma

Journal of Cosmetic Dermatology, Volume 21, Issue 9, Page 3707-3728, September 2022., 2022
Abstract Melasma is a common malady affecting all races with a higher incidence in Hispanics, Middle Eastern, Asians, and African origin females (Fitzpatrick skin phototypes III–V). Women are affected much more often than men. Melasma remains a significant cause of cosmetic morbidity and psychosocial embarrassment affecting quality of life ...
Vikram K. Mahajan, Anant Patil, Leszek Blicharz, Martin Kassir, Nellie Konnikov, Michael H. Gold, Mitchel P. Goldman, Hassan Galadari, Mohamad Goldust   +8 more
wiley   +1 more source

Analysis of urgent follow up visits and complications after intravitreal injections: a retrospective cohort study

International Journal of Retina and Vitreous, 2022
Background Intravitreal injections (IVIs), a common treatment in ophthalmology, result in acute complications and urgent follow-up visits causing significant burden to both patient and physician.
Alexander Miller, Matthew A. Wilneff, Andrew Yazji, Emily Petrinec, Michael Carbone, Chase Miller, Christina McCrossin, Richard Donkor, David G. Miller   +8 more
doaj   +1 more source

SMALL-GAUGE TECHNIQUES FOR REMOVING A FLUOCINOLONE ACETONIDE IMPLANT

RETINAL Cases & Brief Reports, 2023
Purpose: Long-acting injectable fluocinolone releasing implants are used in clinical practice. Although limited in scope, situations may arise where removal of the implant is warranted. We set out to describe possible explantation techniques and to determine whether these implants can be safely removed from a standard ...
Knight, Darren K, Wang, Angeline L, Tsao, Sean W, Carter, Steven L, Mehta, Mitul C   +4 more
openaire   +4 more sources

The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus.

Ophthalmic Surgery Lasers and Imaging Retina, 2023
BACKGROUND AND OBJECTIVE To better understand the level of agreement among retina specialists on the role of inflammation in diabetic retinopathy (DR) and diabetic macular edema (DME), and the use of 0.19-mg fluocinolone acetonide (FAc) implant in DME ...
A. Kolomeyer, David A. Eichenbaum, Daniel F. Kiernan, I. Suñer, S. Hariprasad   +4 more
semanticscholar   +1 more source

Effectiveness of the Dexamethasone Intravitreal Implant for Treatment of Patients with Diabetic Macular Oedema [PDF]

, 2014
Diabetic macular oedema (DMO) is a leading cause of vision loss in the working-age population worldwide. Corticosteroid drugs have been demonstrated to inhibit the expression of both the vascular endothelial growth factor (VEGF) gene and other anti ...
Alkabes, M, Dutra-Medeiros, M, Nucci, P
core   +1 more source

Ranibizumab For Diabetic Macular Edema Refractory To Multiple Prior Treatments [PDF]

, 2016
Purpose: Diabetic macular edema can be refractory to multiple treatment modalities. Although there have been anecdotal reports of ranibizumab showing efficacy when other modalities provided limited benefit, little has been published on treatment for ...
Ciulla, Lauren, Ciulla, Thomas A., Harris, Alon, Hussain, Rehan M., Sink, Bethany   +4 more
core   +2 more sources